vimarsana.com
Home
Live Updates
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results : vimarsana.com
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
Deployed new digital chemistry technology, together with NVIDIA, to predict the ligand-protein interactions for approximately 36 billion compounds in the Enamine REAL Space, reported to be the...
Related Keywords
Utah ,
United States ,
Canada ,
Toronto ,
Ontario ,
Salt Lake City ,
Canadian ,
Wilson Sonsini Goodrich Rosati ,
Chris Gibson ,
Morningstar Sustainalytics ,
Nathan Hatfield ,
David Mauro ,
Toronto Office ,
Foundation Model Construction ,
Partnership Value ,
Twitter ,
Exchange Commission ,
International Conference For Machine ,
Nvidia ,
Development Expenses ,
Recursion Pharmaceuticals Inc ,
Linkedin ,
Cavernous Malformation ,
Adenomatous Polyposis ,
Proficient Ovarian Cancer ,
Target Gamma ,
Valence Discovery ,
Model Construction ,
Language Models ,
International Conference ,
Machine Learning ,
Valence Labs ,
Medical Officer ,
Chief Medical ,
New Drug ,
Legal Officer ,
Chief Legal ,
Wilson Sonsini Goodrich ,
Canadian Headquarters ,
Administrative Expenses ,
San Francisco Bay ,
Consolidated Statements ,
Consolidated Balance Sheets ,
Securities Litigation Reform Act ,
Quarterly Report ,
Annual Report ,
Markets ,
vimarsana.com © 2020. All Rights Reserved.